Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 6;12(1):133.
doi: 10.3390/diagnostics12010133.

Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection?

Sabine Skrebinska  1   2 , Francis Megraud  3   4 , Ilva Daugule  1 , Daiga Santare  1   5 , Sergejs Isajevs  1   6 , Inta Liepniece-Karele  1   6 , Inga Bogdanova  1   6 , Dace Rudzite  1   5 , Reinis Vangravs  1 , Ilze Kikuste  1   7 , Aigars Vanags  1   7 , Ivars Tolmanis  7 , Selga Savcenko  1   5 , Chloé Alix  3   4 , Rolando Herrero  8   9 , Jin Young Park  9 , Marcis Leja  1   7
Affiliations

Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection?

Sabine Skrebinska et al. Diagnostics (Basel). .

Abstract

Background: Discrepancies between histology and serology results for Helicobacter pylori detection could be caused by a variety of factors, including a biopsy sampling error, expertise of the pathologist, natural loss of infection due to advanced atrophy, or a false-positive serology in the case of a previous infection, since antibodies may be present in blood following recovery from the infection.

Aims: To identify true H. pylori-positive individuals in discrepant cases by serology and histology using real time polymerase chain reaction (RT-PCR) as a gold standard.

Methods: Study subjects with discrepant histology and serology results were selected from the GISTAR pilot study data base in Latvia. Subjects having received previous H. pylori eradication therapy or reporting use of proton pump inhibitors, antibacterial medications, or bismuth containing drugs one month prior to upper endoscopy were excluded. We compared the discrepant cases to the corresponding results of RT-PCR performed on gastric biopsies.

Results: In total, 97 individuals with discrepant results were identified: 81 subjects were serology-positive/histology-negative, while 16 were serology-negative/histology-positive. Among the serology-positive/histology-negative cases, 64/81 (79.0%) were false-positives by serology and, for the majority, inflammation was absent in all biopsies, while, in the serology-negative/histology-positive group, only 6.2% were proven false-positives by histology.

Conclusions: Among this high H. pylori prevalent, middle-aged population, the majority of discrepant cases between serology and histology were due to false positive-serology, rather than false-negative histology. This confirms the available evidence that the choice of treatment should not be based solely on the serological results, but also after excluding previous, self-reported eradication therapy.

Keywords: H. pylori; discrepant cases; histology; polymerase chain reaction; serology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study design.
See this image and copyright information in PMC

References

    1. Malfertheiner P., Mégraud F., O’Morain C., Hungin A.P.S., Jones R., Axon A., Graham D.Y., Tytgat G. Current concepts in the management of Helicobacter pylori infection—The Maastricht 2-2000 Consensus Report. Aliment. Pharm. 2002;16:167–180. doi: 10.1046/j.1365-2036.2002.01169.x. - DOI - PubMed
    1. Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J.P., Kuipers E.J., Axon A.T., Bazzoli F., Gasbarrini A., Atherton J., Graham D.Y., et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2016;66:6–30. doi: 10.1136/gutjnl-2016-312288. - DOI - PubMed
    1. Kokkola A., Rautelin H., Puolakkainen P., Sipponen P., Färkkilä M., Haapiainen R., Kosunen T.U. Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis. J. Clin. Microbiol. 1998;36:1808–1810. doi: 10.1128/JCM.36.6.1808-1810.1998. - DOI - PMC - PubMed
    1. Karnes W.E., Jr., Samloff I.M., Siurala M., Kekki M., Sipponen P., Kim S.W., Walsh J.H. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology. 1991;101:167–174. doi: 10.1016/0016-5085(91)90474-Y. - DOI - PubMed
    1. Miernyk K.M., Bruden D.L., Bruce M.G., McMahon B.J., Hennessy T.W., Peters H.V., Hurlburt D.A., Sacco F., Parkinson A.J. Dynamics of Helicobacter pylori-specific immunoglobulin G for 2 years after successful eradication of Helicobacter pylori infection in an American Indian and Alaska Native population. Clin. Vaccine Immunol. 2007;14:85–86. doi: 10.1128/CVI.00253-06. - DOI - PMC - PubMed

LinkOut - more resources